BlackRock Inc. - TREACE MED CONCEPTS INC ownership

TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 86 filers reported holding TREACE MED CONCEPTS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$45,325,230
-43.2%
3,457,302
+10.8%
0.00%
-50.0%
Q2 2023$79,823,669
+22.1%
3,120,550
+20.2%
0.00%0.0%
Q1 2023$65,370,165
+20.3%
2,595,084
+9.8%
0.00%0.0%
Q4 2022$54,349,649
+8.5%
2,364,056
+4.2%
0.00%0.0%
Q3 2022$50,074,000
+89.4%
2,268,911
+23.1%
0.00%
+100.0%
Q2 2022$26,438,000
-12.9%
1,843,561
+14.9%
0.00%0.0%
Q1 2022$30,352,000
+7.2%
1,605,189
+5.7%
0.00%0.0%
Q4 2021$28,310,000
+53.4%
1,518,826
+121.3%
0.00%0.0%
Q3 2021$18,461,000
-13.5%
686,235
+0.6%
0.00%0.0%
Q2 2021$21,331,000682,3410.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q2 2022
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,537,271$38,723,8564.26%
Millrace Asset Group, Inc. 72,595$1,8292.13%
Divisadero Street Capital Management, LP 175,000$4,408,2501.93%
Perceptive Advisors 2,442,250$61,520,2781.82%
SECTORAL ASSET MANAGEMENT INC 366,443$9,230,6991.77%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,234,8411.67%
EMERALD ADVISERS, LLC 1,363,453$34,345,3811.65%
FORMULA GROWTH LTD 124,900$3,146,2311.01%
Novo Holdings A/S 540,000$13,602,6000.90%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 755,379$19,027,9970.78%
View complete list of TREACE MED CONCEPTS INC shareholders